Sens. Rand Paul (R-KY) and Cory Booker (D-NJ) (Olivier Douliery/Sipa USA/Sipa via AP Images)

Un­like­ly duo leads bi­par­ti­san Sen­ate bill to ex­pand Right to Try in­to MD­MA and psilo­cy­bin

Sens. Cory Book­er (D-NJ) and Rand Paul (R-KY) like­ly don’t share much in com­mon when it comes to pol­i­cy views, but that didn’t stop the pair from in­tro­duc­ing a new bill this week that would al­ter the con­tro­ver­sial Right to Try Act to al­low ter­mi­nal­ly ill pa­tients to ac­cess Sched­ule I drugs af­ter a Phase I tri­al has been com­plet­ed.

Build­ing off its pre­de­ces­sor, the bill would skirt around the FDA’s ex­pand­ed ac­cess pro­gram and the DEA’s reg­u­la­tions around con­trolled sub­stances, and al­low pa­tients to po­ten­tial­ly ac­cess Sched­ule I drugs — like MD­MA and psilo­cy­bin — much more eas­i­ly, as the sen­a­tors say these drugs “have shown ex­cep­tion­al promise in treat­ing a va­ri­ety of men­tal health con­di­tions, in­clud­ing sui­ci­dal de­pres­sion, anx­i­ety, and PTSD.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.